Neurogenetic Pharmaceuticals is engaged in the R&a;D of therapeutics for neurodegenerative disorders such as Alzheimer’s disease.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Del Mar
State: California
Zip:
Country: United States
Neurogenetic Pharmaceuticals, Inc. (NGP) is a biopharmaceutical discovery and development company founded in 2009 which is focused on developing innovative drug therapies for use in the treatment of neurodegenerative disorders such as Alzheimer’s disease. Based in San Diego, Calif., the company’s next objective is to obtain an Investigational New Drug approval for its clinical candidate, NGP 555. This compound is expected to prevent the deposition of amyloid plaques in the brain, thereby precluding neuronal cell death and the dementia associated with AD. Future clinical trials will utilize specific Αβ biomarkers and/or brain scanning as an early diagnostic and to monitor drug efficacy in clinical trials. NGP licensed the GSM intellectual property from TPTX and expanded its portfolio to include issued patents in the US, Europe, China, India, Japan, Australia, and other countries.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2014 | Venture Round | $100k | 11/2015 | Grant | $2.5M | 3/2015 | Debt Financing | $50k | 10/2012 | Debt Financing | $250k | 1/2012 | Venture Round | 1 | - |
Abbott Biotech Ventures Abbott Biotech Ventures |
7/2010 | Venture Round | $1.1M | 1/2012 | Venture Round | 1 | - |
Abbott Biotech Ventures Abbott Biotech Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|